NCT07402031 Predicting Weight Loss After Pharmacological or Surgical Treatment in Patients With Obesity
| NCT ID | NCT07402031 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université Catholique de Louvain |
| Condition | Obesity & Overweight |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-05-05 |
| Primary Completion | 2032-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-05-05 with a primary completion date of 2032-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
As with other nutritional strategies, the clinical response to bariatric surgery can be highly variable, with weight regain being a frequent occurrence. Recent evidence on anti-obesity medication indicate similar inter-individual variability in clinical response. Among multiples factors, co-occurrence of eating disorders such as binge eating disorder has been implicated in insufficient clinical response. Improving our ability to predict how patients will respond to obesity treatment is necessary in order to tailor the care pathways we offer. The mechanisms involved in disturbances of eating behaviour before and after surgery remain largely unknown. This study aims to identify the predictive factors of weight loss after pharmacological or surgical treatment, as well as the cognitive and biological mechanisms that mediate this effect.
Eligibility Criteria
Inclusion criteria: * Age between 18 and 65 years * Obesity, with bariatric surgery indicated after a multidisciplinary evaluation in case of surgical treatment. * Good physical and mental health, enabling informed consent. * French speaker Exclusion criteria: * Legal protection * Pregnancy or breastfeeding * History of bariatric surgery (except gastric banding, provided it was removed more than five years ago). * Acute or progressive chronic disease * Alcohol consumption of more than 20 g/day * Inflammatory bowel disease; * Digestive autonomic diabetic neuropathy. * Consumption of dietary supplements (stanols, probiotics, prebiotics or omega-3). * Following a vegan or gluten-free diet or being lactose intolerant. * Fibre consumption \>30 g/day * Recent change in antidiabetic medication within the past 3 months.
Contact & Investigator
Amandine Everard, Professor
STUDY DIRECTOR
Université Catholique de Louvain
Frequently Asked Questions
Who can join the NCT07402031 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obesity & Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07402031 currently recruiting?
Yes, NCT07402031 is actively recruiting participants. Contact the research team at amandine.everard@uclouvain.be for enrollment information.
Where is the NCT07402031 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT07402031 clinical trial?
NCT07402031 is sponsored by Université Catholique de Louvain. The principal investigator is Amandine Everard, Professor at Université Catholique de Louvain. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.